proquazone

This page covers all proquazone drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Epidermal growth factor receptor, Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2.

Targets

Epidermal growth factor receptor, Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2

Phase 2 pipeline (1)

• Anthrex · Other
  Proquazone works by directly interacting with the Epidermal Growth Factor Receptor (EGFR) to potentially inhibit its activity.

Patent intelligence

• proquazone patent landscape — aggregated cliff calendar, attackable patents, originator estates